LEADER 03659nam  2200877z- 450 
001 9910580213103321
005 20231214133530.0
035   $a(CKB)5690000000011957
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/87541
035   $a(EXLCZ)995690000000011957
100   $a20202207d2022      |y             0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aThe Role of Fibrinolytic System in Health and Disease
210   $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022
215   $a1 electronic resource (170 p.)
311   $a3-0365-4619-7 
311   $a3-0365-4620-0 
330   $aThis is a review of the topic of fibrinolysis contributed by authors who are specialized in the clinical and basic studies of this topic. These include: the endothelial receptor of tissue plasminogen activator, by Dr. Katherine Hajjar; regulation of S100 by pml-rar-alpha oncoprotein, by Dr. O?Connell; receptor of urokinase type plasminogen activator, by Dr. M. Ploug et al.; tissue plasminogen activator induction in purjinjen neuron, by Dr. Seeds; fibrinolysis from the blood to the brain, by Dr. Robert Metcalf; tissue plasminogen activator induces the opening of the blood?brain barrier, by Dr. M. Yepes; fibrinolysis shutdown in trauma: a historical review and clinical application, by Drs. Hunter Moore and Ernest Moore; fibrinolysis in immunity, by Drs. K. Kolev and Robert Medcalf; the role of plasminogen activator inhibitor 1, by Drs. M. Erin, A.E. Boe, and E.A. Klyachko; and finally, persistent fibrinolysis shutdown is associated with increased mortality in severely injured trauma patients, by J.P. Meizoso.
606   $aResearch & information: general$2bicssc
606   $aBiology, life sciences$2bicssc
610   $aCOVID-19
610   $afibrinolysis
610   $arenin-aldosterone-angiotensin-system (RAAS)
610   $aplasminogen activator inhibitor 1 (PAI-1)
610   $aurokinase plasminogen activator
610   $aurokinase plasminogen activator receptor
610   $aplasminogen activator inhibitor-1
610   $aacute lung injury and repair and pleural injury and pleural organization
610   $aPAI-1
610   $acardiovascular disease
610   $acancer
610   $ainflammation
610   $afibrosis
610   $aaging
610   $aobstructive sleep apnoea
610   $aOSA
610   $acoagulation
610   $aplatelets
610   $abrown adipose tissue
610   $aobesity
610   $aplasminogen activation
610   $aimmune response
610   $athrombin activatable fibrinolysis inhibitor
610   $aTAFI
610   $aproCPU
610   $aproCPB
610   $aproCPR
610   $acarboxypeptidase
610   $auPA
610   $auPAR
610   $aPA system
610   $atissue-type plasminogen activator (tPA)
610   $aurokinase-type plasminogen activator (uPA)
610   $aneurodegeneration
610   $athrombin
610   $ashear
610   $aclot retraction
610   $aFactor XIII
610   $aclot stability
610   $aNETs
610   $aplasmin
610   $aplasminogen activator
610   $aPAI-2
610   $aantiplasmin
615  7$aResearch & information: general
615  7$aBiology, life sciences
700   $aKwaan$b Hau C$4edt$01313401
702   $aKwaan$b Hau C$4oth
906   $aBOOK
912   $a9910580213103321
996   $aThe Role of Fibrinolytic System in Health and Disease$93031385
997   $aUNINA